ICU Medical (NASDAQ:ICUI) versus Ingen Technologies (OTCMKTS:IGNT) Critical Comparison

ICU Medical (NASDAQ:ICUI) and Ingen Technologies (OTCMKTS:IGNT) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

Analyst Recommendations

This is a summary of recent ratings and target prices for ICU Medical and Ingen Technologies, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ICU Medical	1	0	3	2	3.00
Ingen Technologies	0	0	0	0	0.00

ICU Medical presently has a consensus target price of $168.00, suggesting a potential upside of 22.20%. Given ICU Medical’s stronger consensus rating and higher probable upside, analysts plainly believe ICU Medical is more favorable than Ingen Technologies.

Profitability

This table compares ICU Medical and Ingen Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ICU Medical	2.15%	7.50%	3.91%
Ingen Technologies	N/A	N/A	N/A

Valuation and Earnings

This table compares ICU Medical and Ingen Technologies”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ICU Medical	$2.23 billion	1.54	$730,000.00	$1.85	74.31
Ingen Technologies	N/A	N/A	N/A	N/A	N/A

ICU Medical has higher revenue and earnings than Ingen Technologies.

Volatility & Risk

ICU Medical has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500. Comparatively, Ingen Technologies has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500.

Institutional & Insider Ownership

96.1% of ICU Medical shares are held by institutional investors. 2.1% of ICU Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

ICU Medical beats Ingen Technologies on 11 of the 11 factors compared between the two stocks.

About ICU Medical

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

About Ingen Technologies

Ingen Technologies, Inc. engages in the research and development of home healthcare products for the respiratory industry in United States. It offers oxygen flow meters and nasal cannulas under the Oxyview and Smart Nasal Cannula trademark names for patients suffering with chronic obstructive pulmonary disease. The company was founded in 1999 and is based in Riverside, California.